[Stability of a new thermostable 17D yellow fever vaccine].
作者信息
Durand J P, Kollo B, Merlin M, Le Hesran J Y, Josse R, Garrigue G P
机构信息
Centre Pasteur du Cameroun, Yaoundé, République du Cameroun.
出版信息
J Biol Stand. 1988 Jan;16(1):1-7. doi: 10.1016/0092-1157(88)90023-6.
PMID:3350820
Abstract
摘要
相似文献
1
[Stability of a new thermostable 17D yellow fever vaccine].[一种新型热稳定17D黄热病疫苗的稳定性]
J Biol Stand. 1988 Jan;16(1):1-7. doi: 10.1016/0092-1157(88)90023-6.
2
Comparative clinical study of a new 17D thermostable yellow fever vaccine.
Vaccine. 1986 Sep;4(3):163-5. doi: 10.1016/0264-410x(86)90004-6.
3
Thermostability and efficacy in the field of a new, stabilized yellow fever virus vaccine.
Vaccine. 1985 Sep;3(3):313-5. doi: 10.1016/s0264-410x(85)90182-3.
4
The development of an improved experimental yellow fever vaccine.
J Biol Stand. 1980;8(1):23-34. doi: 10.1016/s0092-1157(80)80044-8.
5
Stability of yellow fever vaccine.黄热病疫苗的稳定性。
Dev Biol Stand. 1996;87:219-25.
6
[Use of stabilized yellow fever vaccine 17D at the time of the yellow fever epidemic in Burkina Faso in 1983].[1983年布基纳法索黄热病流行期间稳定化黄热病疫苗17D的使用情况]
Bull Soc Pathol Exot Filiales. 1985;78(4):536-40.
7
The thermal stability of a stabilized 17D yellow fever virus vaccine.
J Biol Stand. 1977;5(3):173-9. doi: 10.1016/s0092-1157(77)80002-4.
8
Randomized, double-blind, multicenter study of the immunogenicity and reactogenicity of 17DD and WHO 17D-213/77 yellow fever vaccines in children: implications for the Brazilian National Immunization Program.17DD和世界卫生组织17D-213/77黄热病疫苗在儿童中的免疫原性和反应原性的随机、双盲、多中心研究：对巴西国家免疫规划的影响
Vaccine. 2007 Apr 20;25(16):3118-23. doi: 10.1016/j.vaccine.2007.01.053. Epub 2007 Jan 22.
9
Persistence of neutralizing antibody 30-35 years after immunization with 17D yellow fever vaccine.17D 黄热病疫苗免疫后 30 - 35 年中和抗体的持续性。
Bull World Health Organ. 1981;59(6):895-900.
10
Studies on yellow fever vaccine. II--Stability of the reconstituted product.黄热病疫苗研究。II——复溶产品的稳定性。
J Biol Stand. 1988 Apr;16(2):71-6. doi: 10.1016/0092-1157(88)90033-9.
Zotero 插件